-
公开(公告)号：DE59304311D1
公开(公告)日：1996-11-28
申请号：DE59304311
申请日：1993-06-08
Applicant: BASF AG
Inventor： STEINER GERD , UNGER LILIANE , BEHL BERTHOLD , TESCHENDORF HANS-JUERGEN
IPC: C07D401/04 , A61K31/40 , A61K31/403 , A61K31/4427 , A61K31/4433 , A61K31/4439 , A61K31/445 , A61P25/00 , A61P25/02 , A61P25/20 , A61P43/00 , C07D209/52 , C07D409/04
-
公开(公告)号：NO964121L
公开(公告)日：1996-11-26
申请号：NO964121
申请日：1996-09-27
Applicant: BASF AG
Inventor： BAUMANN ERNST , VOGELBACHER UWE JOSEF , RHEINHEIMER JOACHIM , KLINGE DAGMAR , RIECHERS HARTMUT , KROGER BURKHARD , BIALOJAN SIEGFRIED , BOLLSCHWEILER CLAUS , WERNET WOLFGANG , UNGER LILIANE , RASCHACK MANFRED
IPC: A61K31/00 , C07D251/26 , A61K31/505 , A61K31/506 , A61K31/53 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , A61P39/02 , C07D239/26 , C07D239/34 , C07D239/38 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , A61K
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I I
-
公开(公告)号：HU9601511D0
公开(公告)日：1996-07-29
申请号：HU9601511
申请日：1994-11-26
Applicant: BASF AG
Inventor： HOEGER THOMAS , MUNSHAUER RAINER , STEINER GERD , TESCHENDORF HANS-JUERGEN , UNGER LILIANE
IPC: C07D401/04 , A61K31/40 , A61K31/403 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/505 , A61P25/00 , A61P25/02 , A61P25/08 , A61P25/18 , A61P25/28 , A61P43/00 , C07D209/02 , C07D209/46 , C07D209/52 , C07D209/90 , C07D209/96 , C07D403/04 , C07D403/06 , C07D405/06 , C07D409/04 , C07D409/06 , C07D413/06
Abstract: PCT No. PCT/EP94/03910 Sec. 371 Date Apr. 19, 1996 Sec. 102(e) Date Apr. 19, 1996 PCT Filed Nov. 26, 1994 PCT Pub. No. WO95/15312 PCT Pub. Date Jun. 8, 1995Compounds of the formula I I where the substituents have the meanings given in the description, and their preparation are described. The novel compounds are suitable for the control of diseases.
-
公开(公告)号：FI962324A0
公开(公告)日：1996-06-03
申请号：FI962324
申请日：1996-06-03
Applicant: BASF AG
Inventor： STEINER GERD , MUNSCHAUER RAINER , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , HOEGER THOMAS
IPC: A61K31/40 , A61K31/403 , A61K31/404 , A61P21/02 , A61P25/08 , A61P25/20 , A61P25/24 , A61P25/26 , C07D209/14 , C07D209/18 , C07D209/44 , C07D209/52 , C07D487/04 , C07D491/048 , C07D497/04 , C07D
Abstract: PCT No. PCT/EP94/03913 Sec. 371 Date Jun. 6, 1996 Sec. 102(e) Date Jun. 6, 1996 PCT Filed Nov. 26, 1994 PCT Pub. No. WO95/15327 PCT Pub. Date Jun. 8, 1995Compounds of the formula I I where B, R1, R2, n and A have the meanings given in the description, and their preparation are described. The novel compounds are suitable for the control of diseases.
-
公开(公告)号：FI962323A0
公开(公告)日：1996-06-03
申请号：FI962323
申请日：1996-06-03
Applicant: BASF AG
Inventor： STEINER GERD , MUNSCHAUER RAINER , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , HOEGER THOMAS
IPC: C07D401/04 , A61K31/40 , A61K31/403 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/505 , A61P25/00 , A61P25/02 , A61P25/08 , A61P25/18 , A61P25/28 , A61P43/00 , C07D209/02 , C07D209/46 , C07D209/52 , C07D209/90 , C07D209/96 , C07D403/04 , C07D403/06 , C07D405/06 , C07D409/04 , C07D409/06 , C07D413/06 , C07D
Abstract: PCT No. PCT/EP94/03910 Sec. 371 Date Apr. 19, 1996 Sec. 102(e) Date Apr. 19, 1996 PCT Filed Nov. 26, 1994 PCT Pub. No. WO95/15312 PCT Pub. Date Jun. 8, 1995Compounds of the formula I I where the substituents have the meanings given in the description, and their preparation are described. The novel compounds are suitable for the control of diseases.
-
Patent Agency Ranking
公开(公告)号：FI962323A
公开(公告)日：1996-06-03
申请号：FI962323
申请日：1996-06-03
Applicant: BASF AG
Inventor： STEINER GERD , MUNSCHAUER RAINER , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , HOEGER THOMAS
IPC: C07D401/04 , A61K31/40 , A61K31/403 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/505 , A61P25/00 , A61P25/02 , A61P25/08 , A61P25/18 , A61P25/28 , A61P43/00 , C07D209/02 , C07D209/46 , C07D209/52 , C07D209/90 , C07D209/96 , C07D403/04 , C07D403/06 , C07D405/06 , C07D409/04 , C07D409/06 , C07D413/06 , C07D
Abstract: PCT No. PCT/EP94/03910 Sec. 371 Date Apr. 19, 1996 Sec. 102(e) Date Apr. 19, 1996 PCT Filed Nov. 26, 1994 PCT Pub. No. WO95/15312 PCT Pub. Date Jun. 8, 1995Compounds of the formula I I where the substituents have the meanings given in the description, and their preparation are described. The novel compounds are suitable for the control of diseases.
-
公开(公告)号：CA2201785A1
公开(公告)日：1996-04-25
申请号：CA2201785
申请日：1995-10-07
Applicant: BASF AG
Inventor： AMBERG WILHELM , KLING ANDREAS , RIECHERS HARTMUT , KLINGE DAGMAR , WERNET WOLFGANG , UNGER LILIANE , RASCHACK MANFRED , MUELLER STEFAN , BAUMANN ERNST , RHEINHEIMER JOACHIM , VOGELBACHER UWE JOSEF
IPC: C07D251/30 , A61K31/505 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P11/08 , A61P13/02 , A61P15/00 , A61P25/04 , C07D239/00 , C07D239/26 , C07D239/28 , C07D239/34 , C07D239/38 , C07D239/60 , C07D239/70 , C07D239/96 , C07D251/12 , C07D251/52 , C07D257/02 , C07D309/00 , C07D403/06 , C07D403/12 , C07D405/12 , C07D417/12 , C07D487/04 , C07D491/04 , C07D491/044 , C07D491/048
Abstract: Carboxylic acid derivatives have the formula (I), in which R to R6, X, Y, and Z have the meanings given in the description. Also disclosed is their preparation. These new compounds are useful for controlling diseases.
-
公开(公告)号：CA2195242A1
公开(公告)日：1996-02-01
申请号：CA2195242
申请日：1995-07-14
Applicant: BASF AG
Inventor： HELLENDAHL BEATE , LANSKY ANNEGRET , RENDENBACH-MUELLER BEATRICE , BACH ALFRED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE KARSTEN
IPC: C07D233/84 , A61K31/33 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4425 , A61K31/445 , A61K31/495 , A61K31/496 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , C07D213/56 , C07D213/64 , C07D213/65 , C07D213/70 , C07D213/73 , C07D213/79 , C07D213/81 , C07D233/90 , C07D307/79 , C07D333/24 , C07D333/28 , C07D333/38 , C07D471/18 , A61K31/52 , A61K31/505 , A61K31/53
Abstract: The present invention relates to the use of heterocyclic compounds of formula (I) Het - A - B - Ar in which Het A, B and Ar have the meanings given in the description. The compounds of the invention have a high affinity for the dopamine-D3-receptor and are therefore usable for the treatment of diseases responding to dopamine-D3-ligands.
-
公开(公告)号：CA2195240A1
公开(公告)日：1996-02-01
申请号：CA2195240
申请日：1995-07-14
Applicant: BASF AG
Inventor： HELLENDAHL BEATE , LANSKY ANNEGRET , RENDENBACH-MUELLER BEATRICE , BACH ALFRED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE KARSTEN
IPC: C07D277/22 , A61K31/425 , A61K31/426 , A61K31/433 , A61K31/435 , A61K31/44 , A61K31/4439 , A61K31/445 , A61K31/454 , A61K31/496 , A61K31/54 , C07D277/20 , C07D277/32 , C07D277/36 , C07D277/42 , C07D285/12 , C07D285/125 , C07D285/135 , C07D417/12
Abstract: The use is disclosed of thiazole and thiadiazole compounds having the formula (I), in which R1, A, B and Ar have the meanings given in the description. These compounds have a high affinity to the dopamine D3 receptor and are therefore useful for treating diseases of the central nervous system.
-
140.发明专利
公开(公告)号：NZ253121A
公开(公告)日：1995-12-21
申请号：NZ25312193
申请日：1993-06-08
Applicant: BASF AG
Inventor： STEINER GERD , UNGER LILIANE , BEHL BERTHOLD , TESCHENDORF HANS-JUERGEN , MUNSCHAUER RAINER
IPC: A61K20060101 , A61K31/33 , A61K31/395 , A61K31/40 , A61K31/4045 , A61K31/4184 , A61K31/505 , C07D513/04 , A61K31/506 , A61K31/513 , A61K31/517 , A61K31/519 , A61K31/54 , A61K31/542 , A61P25/00 , A61P25/20 , A61P25/22 , A61P25/24 , A61P43/00 , C07D20060101 , C07D207/00 , C07D209/02 , C07D209/52 , C07D221/00 , C07D239/00 , C07D401/04 , C07D401/06 , C07D401/14 , C07D403/00 , C07D403/04 , C07D403/06 , C07D403/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
Abstract: PCT No. PCT/EP93/01438 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO94/00458 PCT Pub. Date Jan. 6, 1994.Abstract of the Disclosure: Compounds of the formula I I where R1, R2, n , R3, A, X, Y and Z have the meanings stated in the description, and the preparation thereof are described. The novel compounds are suitable for controlling diseases , i.e., as neuroleptics, antidepressants, sedatives, hypnotics, CNS protectives or muscle relaxants.
-
-
-
-
-
-
-
-
-
Search Results
773
records
(took 0.024 seconds)
